ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$114.47

Market cap

$23.92B

P/E Ratio

47.7

Dividend/share

$0.96

EPS

$2.4

Enterprise value

$29.31B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
The net income has surged by 120% year-on-year and by 12% since the previous quarter
The EPS has soared by 118% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com/
Peers: SYK COO XRAY EW

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
208.96M
Market cap
$23.92B
Enterprise value
$29.31B
Valuations
Price to earnings (P/E)
47.7
Price to book (P/B)
1.93
Price to sales (P/S)
3.32
EV/EBIT
34.48
EV/EBITDA
16.47
EV/Sales
4.07
Earnings
Revenue
$7.2B
EBIT
$850.1M
EBITDA
$1.78B
Free cash flow
$716.7M
Per share
EPS
$2.4
Free cash flow per share
$3.44
Book value per share
$59.32
Revenue per share
$34.49
TBVPS
$36.06
Balance sheet
Total assets
$21.29B
Total liabilities
$8.92B
Debt
$5.71B
Equity
$12.37B
Working capital
$2.15B
Liquidity
Debt to equity
0.46
Current ratio
1.96
Quick ratio
0.76
Net debt/EBITDA
3.03
Margins
EBITDA margin
24.7%
Gross margin
71.7%
Net margin
7%
Operating margin
12.1%
Efficiency
Return on assets
2.4%
Return on equity
4.1%
Return on invested capital
8.1%
Return on capital employed
4.5%
Return on sales
11.8%
Dividend
Dividend yield
0.84%
DPS
$0.96
Payout ratio
40%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
-2.45%
1 week
-5.87%
1 month
-0.67%
1 year
8.86%
YTD
-10.22%
QTD
-21.38%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.2B
Gross profit
$5.16B
Operating income
$874.1M
Net income
$505.6M
Gross margin
71.7%
Net margin
7%
The net income has surged by 120% year-on-year and by 12% since the previous quarter
The net margin has surged by 112% year-on-year and by 11% since the previous quarter
Zimmer Biomet Holdings's gross profit has increased by 6% YoY
Zimmer Biomet Holdings's operating income has increased by 6% QoQ and by 2.1% YoY

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
ZBH P/E details
P/E
47.7
P/B
1.93
P/S
3.32
EV/EBIT
34.48
EV/EBITDA
16.47
EV/Sales
4.07
The EPS has soared by 118% YoY and by 13% from the previous quarter
ZBH's P/E is 38% lower than its last 4 quarters average of 79.1
The stock's P/B is 10% below its 5-year quarterly average of 2.2 and 10% below its last 4 quarters average of 2.2
ZBH's equity is up by 2.1% year-on-year
ZBH's price to sales (P/S) is 11% lower than its 5-year quarterly average of 3.8 and 11% lower than its last 4 quarters average of 3.8
The revenue has grown by 4.2% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROA has soared by 140% YoY and by 14% from the previous quarter
Zimmer Biomet Holdings's return on equity has surged by 116% YoY and by 11% QoQ
The ROIC has soared by 88% YoY and by 11% QoQ
The ROS has soared by 69% YoY and by 10% from the previous quarter

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
0.84%
Payout ratio
40%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 139% higher than the total liabilities
ZBH's quick ratio is up by 12% YoY and by 4.1% QoQ
The current ratio has grown by 8% YoY and by 3.7% from the previous quarter
The debt is 54% smaller than the equity
The debt to equity has declined by 8% year-on-year and by 4.2% since the previous quarter
The debt has declined by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.